KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Inventory: 2020-2025

Historic Inventory for Moderna (MRNA) over the last 5 years, with Sep 2025 value amounting to $332.0 million.

  • Moderna's Inventory fell 19.42% to $332.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $332.0 million, marking a year-over-year decrease of 19.42%. This contributed to the annual value of $117.0 million for FY2024, which is 42.08% down from last year.
  • Moderna's Inventory amounted to $332.0 million in Q3 2025, which was up 38.33% from $240.0 million recorded in Q2 2025.
  • Over the past 5 years, Moderna's Inventory peaked at $2.1 billion during Q3 2022, and registered a low of $117.0 million during Q4 2024.
  • Its 3-year average for Inventory is $369.0 million, with a median of $332.0 million in 2025.
  • As far as peak fluctuations go, Moderna's Inventory skyrocketed by 2,965.96% in 2021, and later tumbled by 78.71% in 2023.
  • Over the past 5 years, Moderna's Inventory (Quarterly) stood at $1.4 billion in 2021, then plummeted by 34.14% to $949.0 million in 2022, then tumbled by 78.71% to $202.0 million in 2023, then crashed by 42.08% to $117.0 million in 2024, then decreased by 19.42% to $332.0 million in 2025.
  • Its Inventory was $332.0 million in Q3 2025, compared to $240.0 million in Q2 2025 and $128.0 million in Q1 2025.